Dimensional Fund Advisors
CYTK icon

Dimensional Fund Advisors’s Cytokinetics CYTK Stock Holding History

Dimensional Fund Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.23M Buy
94,503
+40,574
+75% +$2.58M ﹤0.01% 2427
2025
Q4 		$3.43M Buy
53,929
+2,670
+5% +$166K ﹤0.01% 2625
2025
Q3 		$2.82M Buy
51,259
+19,173
+60% +$790K ﹤0.01% 2678
2025
Q2 		$1.06M Buy
32,086
+1,052
+3% +$36.6K ﹤0.01% 2875
2025
Q1 		$1.25M Sell
31,034
-63,090
-67% -$2.9M ﹤0.01% 2832
2024
Q4 		$4.43M Sell
94,124
-25,708
-21% -$1.34M ﹤0.01% 2571
2024
Q3 		$6.33M Sell
119,832
-28,729
-19% -$1.6M ﹤0.01% 2452
2024
Q2 		$8.05M Buy
148,561
+32,372
+28% +$1.95M ﹤0.01% 2343
2024
Q1 		$8.15M Buy
116,189
+112,127
+2,760% +$8.67M ﹤0.01% 2397
2023
Q4 		$339K Buy
+4,062
New +$147K ﹤0.01% 3106
2023
Q3 		– Sell
-23,126
Closed -$754K – 3476
2023
Q2 		$754K Buy
23,126
+419
+2% +$15.5K ﹤0.01% 2979
2023
Q1 		$799K Buy
22,707
+4,438
+24% +$181K ﹤0.01% 2951
2022
Q4 		$837 Sell
18,269
-1,539
-8% -$66.2K ﹤0.01% 2936
2022
Q3 		$960K Buy
+19,808
New +$953K ﹤0.01% 2888
2019
Q4 		– Sell
-24,940
Closed -$284K – 3390
2019
Q3 		$284K Hold
24,940
– – ﹤0.01% 3234
2019
Q2 		$281K Hold
24,940
– – ﹤0.01% 3274
2019
Q1 		$202K Sell
24,940
-168,931
-87% -$1.24M ﹤0.01% 3310
2018
Q4 		$1.23M Sell
193,871
-35,506
-15% -$260K ﹤0.01% 2969
2018
Q3 		$2.26M Buy
229,377
+160,622
+234% +$1.29M ﹤0.01% 2902
2018
Q2 		$571K Sell
68,755
-49,636
-42% -$413K ﹤0.01% 3108
2018
Q1 		$852K Sell
118,391
-34,239
-22% -$294K ﹤0.01% 3026
2017
Q4 		$1.24M Buy
152,630
+7,124
+5% +$80.9K ﹤0.01% 2944
2017
Q3 		$2.11M Sell
145,506
-80,779
-36% -$1.1M ﹤0.01% 2847
2017
Q2 		$2.74M Buy
226,285
+215,885
+2,076% +$3M ﹤0.01% 2778
2017
Q1 		$134K Buy
+10,400
New +$122K ﹤0.01% 3227
2016
Q1 		– Sell
-51,467
Closed -$538K – 3303
2015
Q4 		$538K Sell
51,467
-63,386
-55% -$622K ﹤0.01% 3077
2015
Q3 		$768K Sell
114,853
-1,808
-2% -$12.3K ﹤0.01% 3046
2015
Q2 		$784K Sell
116,661
-1,086
-0.9% -$7.12K ﹤0.01% 3068
2015
Q1 		$798K Buy
117,747
+14,945
+15% +$112K ﹤0.01% 3035
2014
Q4 		$823K Sell
102,802
-2,454
-2% -$10.5K ﹤0.01% 3051
2014
Q3 		$371K Hold
105,256
– – ﹤0.01% 3197
2014
Q2 		$503K Hold
105,256
– – ﹤0.01% 3189
2014
Q1 		$1M Sell
105,256
-1,048
-1% -$9.48K ﹤0.01% 3038
2013
Q4 		$691K Sell
106,304
-4,208
-4% -$27.6K ﹤0.01% 3110
2013
Q3 		$839K Sell
110,512
-3,457
-3% -$37.1K ﹤0.01% 3074
2013
Q2 		$1.32M Buy
+113,969
New +$898K ﹤0.01% 2942

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors's CYTK Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Cytokinetics (CYTK) stake by 75% in Q1 2026, buying an estimated $2.58M and bringing the position to 94,503 shares worth $6.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

Dimensional Fund Advisors first reported a position in CYTK in Q2 2013 and has held it in 36 quarters since. The position peaked at $8.15M in Q1 2024. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Dimensional Fund Advisors held 94,503 shares of Cytokinetics worth $6.23M as of Q1 2026.
  • Dimensional Fund Advisors bought 40,574 Cytokinetics shares in Q1 2026, an estimated $2.58M.
  • Cytokinetics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2427 holding.
  • Dimensional Fund Advisors first reported a position in Cytokinetics in Q2 2013 and has held it in 36 quarters since.
  • Dimensional Fund Advisors's Cytokinetics position peaked at $8.15M in Q1 2024.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.